Celltrion Pharm Inc (068760) — Cash Flow Reinvestment Rate
Celltrion Pharm Inc (068760) has a Cash Flow Reinvestment Rate of 0.95x as of September 2025, reinvesting ₩22.17 Billion (capex ₩2.27 Billion plus investments ₩-19.90 Billion) from operating cash flow of ₩23.44 Billion. Explore 068760 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celltrion Pharm Inc Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Celltrion Pharm Inc across 8 annual periods. Also explore Celltrion Pharm Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Celltrion Pharm Inc (2014–2024)
Year-by-year capital reinvestment analysis for Celltrion Pharm Inc. For live market cap and broader valuation context, see market cap of Celltrion Pharm Inc.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | ₩18.10 Billion | ₩56.59 Billion | ₩5.98 Billion | ▼ -74.8% |
| 2023 | 1.27x | ₩11.12 Billion | ₩8.76 Billion | ₩6.90 Billion | ▲ +310.6% |
| 2021 | 0.31x | ₩28.81 Billion | ₩93.15 Billion | ₩12.50 Billion | ▼ -73.7% |
| 2020 | 1.18x | ₩42.61 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -0.9% |
| 2019 | 1.19x | ₩33.06 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +125.8% |
| 2018 | 0.53x | ₩7.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -85.2% |
| 2015 | 3.55x | ₩47.38 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +131.5% |
| 2014 | 1.53x | ₩26.53 Billion | ₩17.33 Billion | ₩26.16 Billion | — |